Challenge Study Shows Efficacy of RSV Vaccine in Healthy Adults
For healthy adults, the bivalent prefusion F respiratory syncytial virus vaccine is effective against symptomatic RSV infection and viral shedding.
Vaccines
And Then Came Monkeypox: What to Know About the Recent Outbreak
In this interview, Paritosh Prasad, MD, provides insight into the recent outbreak of monkeypox.
Trial to Evaluate Immune Response After Vaccination in Pediatric Patients With Cancer
Patients in the first arm will undergo single booster vaccination, and patients in the second arm will undergo full revaccination.
COVID-19 Vaccines
Types of COVID-19 vaccines in the US, including those approved by the FDA under Emergency Use Authorization, as well as other investigational products currently in Phase 3 clinical trials.
Has the COVID-19 Pandemic Disrupted Routine Immunization Services?
As the medical field shifted its priorities to treating COVID-19 at the start of the pandemic, routine immunization was one of the many medical fields to experience disruption. What was the scope of this disruption and what are possible ways to address it?
Pneumococcal 21-Valent Conjugate Vaccine Gets Breakthrough Therapy Status
The designation was based on data from a phase 1/2 study that evaluated a single intramuscular injection of V116 in pneumococcal-naïve adults.
Effect of 13-Valent Pneumococcal Conjugate Vaccine on Hospitalization in Older Adults
How effective is the 13-valent pneumococcal conjugate vaccine in preventing pneumonia and lower respiratory tract infection hospitalizations in older adults?
Live Attenuated Flu Vaccine Does Not Appear to Increase Frequency of Asthma Exacerbations
For children aged 5 to 17 years with asthma, quadrivalent live attenuated influenza vaccine is noninferior to quadrivalent IIV4 for frequency of asthma exacerbations.
RSV Vaccine Candidate for Older Adults Gets Breakthrough Therapy Designation
The RSVpreF vaccine candidate consists of 2 prefusion F proteins selected to optimize protection against RSV A and B.
Second Booster Dose Authorized to Increase Protection Against COVID-19 for Certain People
The Emergency Use Authorization was based on safety and immunogenicity data provided to the Agency.
- Loading...
Loading...
Next post in General Medicine
Loading... 
Loading...